Clinical trials recruiting in Zibo, China

Phase breakdown

Conditions recruiting in Zibo, China

Recruiting trials in Zibo, China

• A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
  NCT07043725 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
  NCT05150691 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
  NCT07662109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
  NCT07436949 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
  NCT06568471 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
  NCT07670416 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
  NCT07761117 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
  NCT06471257 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
  NCT07775404 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia
  NCT06974266 · Phase: Not applicable (e.g. observational or device study) · Ages: 35 Years to 75 Years · Sex: All (male and female)
• China HeadAche DIsorders RegiStry
  NCT05334927 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
  NCT07796516 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
  NCT07169656 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Phase II Study of RC1416 Injection in COPD
  NCT07402551 · Phase: Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female)
• Phase II Trial of RC1416 Injection in Asthma
  NCT07403487 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
  NCT07198217 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture
  NCT05866029 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 90 Years · Sex: All (male and female)
• TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
  NCT06829784 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study
  NCT07085182 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Zibo, China?

20 recruiting trials have at least one study site in Zibo, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.